Clinical Trials Directory

Trials / Completed

CompletedNCT00169910

VIP: Vascular Imaging Project. Study on the Progression of Cardiovascular Disease in Renal Transplant Recipients

VIP: Vascular Imaging Project. Prospective Randomized Study on the Effect of AUC-monitored Treatment With Steroids Combined With Either a Calcineurin Inhibitor or Mycophenolate Mofetil on the Progression of Subclinical Cardiovascular Disease in Renal Transplant Recipients.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
119 (actual)
Sponsor
Leiden University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective randomized study to compare the influence of area under the curve (AUC)-monitored dual treatment with steroids in combination with either a calcineurin inhibitor (CNI) or mycophenolate mofetil (MMF) on the progression of subclinical cardiovascular disease in renal transplant recipients. Since CNI have a detrimental effect on cardiovascular risk factors, it is the researchers' hypothesis that renal recipients after CNI withdrawal will have more reduction of markers of cardiovascular disease.

Detailed description

Stable renal transplant patients on maintenance immunosuppressive therapy with steroids, a calcineurin inhibitor (CNI) and mycophenolate mofetil (MMF) will be randomized for AUC-monitored withdrawal of either CNI or MMF. The progression of cardiovascular markers will be assessed by yearly measurements of Intima Media Thickness, Pulse Wave Velocity and Left Ventricular Hypertrophy in both groups. The duration of the study will be 3 years and the target sample size is 100 patients per arm

Conditions

Interventions

TypeNameDescription
DRUGAUC monitored withdrawal of MMF or CNIAUC monitored withdrawal of MMF or CNI from a immunosuppressive drug regimen with steroids, CNI and MMF in stable renal transplant recipients

Timeline

Start date
2005-12-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2005-09-15
Last updated
2012-12-17

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00169910. Inclusion in this directory is not an endorsement.